Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07021703RecruitingPhase 1
Rabies vaccine trial for people aged 10 to 60
This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.
Zhengzhou, HenanAges 10–60 - NCT07018544Enrolling by invitation
Wegovy safety and effectiveness study in Korea
This study watches how Wegovy (semaglutide) works and its side effects when given by doctors to patients with obesity or overweight in South Korea. It is not testing a new drug, but collecting information from routine care.
Goyang-si, Gyeonggi-doAges 19 years+ - NCT07023315RecruitingPhase 3
Study of cadonilimab plus SOX before and after surgery for stomach cancer
This trial tests if adding the drug cadonilimab to standard chemotherapy (SOX) before and after surgery can help treat stomach or gastroesophageal junction cancer that can be removed. The goal is to see if this combination improves outcomes for patients.
Beijing, Beijing MunicipalityAges 18–75 - NCT07021963RecruitingPhase 2
Long-term safety study of HRS-1893 for hypertrophic cardiomyopathy
This study tests the long-term safety of the drug HRS-1893 in people with hypertrophic cardiomyopathy who have already been in a previous HRS-1893 study. It helps doctors learn more about how safe the drug is over time.
Beijing, Beijing MunicipalityAges 18–85 - NCT06966154RecruitingPhase 1/Phase 2
Tislelizumab with golidocitinib and selinexor for NK/T-cell lymphoma
This trial tests a combination of three drugs for people with NK/T-cell lymphoma that has come back or not responded to previous treatment. It aims to see if this new mix is safe and effective. You may qualify if your lymphoma returned after certain therapies or didn't respond to them.
Shanghai, ShangaiAges 18 years+ - NCT07021534RecruitingPhase 1
CAR-NK and CAR-T cells for cancer with liver spread
This trial tests a new treatment that uses special immune cells (CAR-NK and CAR-T cells) given directly into the liver artery, then through a vein, to fight advanced solid tumors that have spread to the liver. It is for people who have already tried standard treatments and need new options.
Hangzhou, ZhejiangAges 18–75 - NCT07018076Recruiting
TB treatment study for people who just finished therapy
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
KampalaAges 12 years+ - NCT07016620Recruiting
Laser therapy for BPH after prior treatment
This study tests if laser therapy can help men whose BPH symptoms came back after a previous less invasive procedure. It's a way to treat the blockage without more major surgery.
Cleveland, OhioAges 40 years+ - NCT07015528Enrolling by invitationEarly Phase 1
Drug liking study for surgery patients
This study looks at how much patients like the feeling of a drug given during a procedure. It may help doctors understand which medicines work best for comfort during surgery.
Palo Alto, CaliforniaAges 18 years+ - NCT07014267Recruiting
Virtual reality for calming anxiety during fertility procedures
This trial tests whether using virtual reality (VR) for mindfulness can help reduce anxiety in people undergoing fertility-related surgeries. If you are between 18 and 50 and scheduled for a fertility procedure, you may be able to participate.
Abu DhabiAges 18–50 - NCT07019428Recruiting
A new way to stabilize gum grafts with titanium tacs
This trial tests a method using small titanium tacs to hold a gum graft in place instead of stitches. It may help people with thin gum tissue around dental implants have a more comfortable and effective procedure.
CairoAges 18–40 - NCT07021612Recruiting
Registry study of TAVI for severe aortic regurgitation
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
Hong Kong, ShatinAges 18 years+ - NCT07014852RecruitingEarly Phase 1
Inuit mental health trial with cultural foods and activities
This trial tests whether a program that includes traditional country foods, group conversations, and cultural workshops can improve mental health for Inuit adults. It is designed with Inuit knowledge to make the study feel supportive and relevant.
Arviat, NunavutAges 18–65 - NCT07023653Recruiting
ACL repair: comparing all-inside vs. standard tunnel surgery
This study compares two ways of repairing a torn ACL: a newer 'all-inside' method versus a standard tunnel method. It is designed for adults with a simple ACL tear, not for those with multiple ligament injuries, severe cartilage damage, or active infection.
DepokAges 18–65 - NCT07022496RecruitingPhase 4
Can oral caffeine help with acute migraine attacks?
This trial tests whether taking caffeine by mouth can reduce the severity of a migraine attack when it happens. It may offer a simple, at-home option for people with different types of migraine.
CairoAges 18–60 - NCT07018947RecruitingPhase 2
Atezolizumab and bevacizumab before and after surgery for liver cancer
This trial tests whether adding two drugs (atezolizumab and bevacizumab) before and after surgery can lower the chance of liver cancer coming back in people with high-risk HCC. You must be eligible for surgical removal of your tumor.
Badalona, BarcelonaAges 18 years+ - NCT07017062Recruiting
Study of ceramic veneers bonded with two self-adhesive dental cements
This trial compares two types of self-adhesive resin cements for bonding ceramic occlusal veneers. It aims to see which cement works better for restoring back teeth while keeping your natural tooth structure.
CairoAges 21 years+ - NCT06995976RecruitingEarly Phase 1
Testing a new CD73-targeting probe for imaging
This early-phase trial tests a new imaging probe that targets a protein called CD73 on cells. It helps doctors see how the probe works in your body and if it could be used for diagnosis in the future.
Fuzhou, FujianAges 18–90 - NCT06996704RecruitingPhase 1
Study of AK0610 in healthy adults
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
Jinan, ShandongAges 18–50 - NCT05518253RecruitingPhase 1
CAR-T treatment for CD70-positive advanced solid tumors
This trial tests a lab-made immune therapy (CAR-T) that targets a protein called CD70 found on some advanced cancers. It’s designed for people whose solid tumors have spread and no standard treatments have worked or weren’t tolerated.
Hangzhou, ZhejiangAges 18 years+ - NCT07010094Recruiting
Shockwave balloons for hardened heart artery blockages
This trial tests a special balloon that uses shock waves to crack calcium in heart arteries, making it easier to place a stent. It is for people with chest pain or signs of heart strain due to a single, severely blocked artery with dense calcium.
Fujian, XiamenAges 18–85 - NCT07010107RecruitingPhase 3
Testing anaprazole for moderate to severe reflux esophagitis
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07008976RecruitingPhase 3
Testing TQB2102 versus standard treatment for HER2-positive advanced breast cancer
This trial tests a new drug called TQB2102 against a standard treatment (Kadcyla) for people with HER2-positive breast cancer that has spread or cannot be removed. It is for those whose cancer has worsened after previous HER2-targeted therapy.
Bengbu, AnhuiAges 18–75 - NCT07003841Recruiting
AR-guided breast cancer localization trial
This trial tests an augmented reality (AR) tool to help surgeons locate breast cancer tumors during breast-conserving surgery. You may join if you have a single, small invasive breast tumor and have not had chemotherapy before surgery.
Seoul, Gangseo-guAges 19–80
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.